Ricin Toxin

Author(s): Rayanne Hilsen, Scott J. Jager and John W. Cherwonogrodzky

DOI: 10.2174/9781608058785114010009

Generic Antibody Therapy, Polyclonal and Monoclonal, on Ricin Toxin Extracted from Several Cultivars of the Castor Plant (Ricinus Communis)

Pp: 98-109 (12)

Buy Chapters
  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Castor beans, from 10 different cultivars of Ricinus communis, were acquired from different commercial sources from three different countries. Ricin was extracted from 25 grams of beans from each cultivar. Resulting toxin yields varied from negligible to relatively high. Two methods of extraction were used, with one method yielding on average 7-fold more toxin than the other. Reducing SDS-PAGE showed that most of the ricin extractions had not only the A and B chains, but also additional bands of comparable molecular weights similar to those noted in the historical literature. Results from intra-peritoneal injection (i.p.) of mice, given the same amount of ricin extracted from different cultivars, varied in toxicity up to 10-fold. Regardless of the different sources of ricin, both polyclonal goat anti-ricin antisera and monoclonal mouse antibody (mD9) inhibited all of these, rescuing mice from 5 LD50 of toxin when given via i.p. an hour later.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books